Clinical Trial Update: SP2086 Pharmacokinetic Study in Renal Insufficiency Patients [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluating SP2086 in patients with renal insufficiency to assess how kidney impairment affects drug exposure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Insufficiency

Drugs mentioned

• SP2086

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Renal Insufficiency | Phase 1 | Status: COMPLETED